Skip to content
DataLookout
Menu

2009-APBINCT01185132

Intensity Modulated Radiotherapy (IMRT) vs. 3D-conformal Accelerated Partial Breast Irradiation (APBI) for Early Stage Breast Cancer After Lumpectomy

StatusRecruiting
PhasePhase 3
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 6 versions: 5 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Minor Study sites: 4 to 5
    • Secondary endpoints revised (7)
    v6
  2. Minor Site contacts updated at 1 of 4 sitesv5
  3. Notable Enrollment target: 300 to 660v3
  4. Notable Eligibility criteria shortened, about 1 word
    • Study sites: 5 to 4
    v2
  5. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Prevalence of breast pain after Accelerated Partial Breast Radiotherapy (APBI)
Timeframe: 5 years
Prevalence of chest wall pain after Accelerated Partial Breast Radiotherapy (APBI)
Timeframe: 2-5 years

Secondary (7)

Dosimetric comparison
Acute skin reactions
Cosmetic outcomes after APBI
Ipsilateral breast event
Cause specific survival
Show 2 moreShow less
Disease free survival
Overall survival

Arms and interventions

IMRTExperimental

Intensity modulated radiotherapy, 38.5 Gy, 10 fractions over 5 days

3D-CRTActive comparator

Three dimensional conformal external radiotherapy, 38.5 Gy, 10 fractions over 5 days

Radiation: accelerated partial breast irradiation - 3D-conformal planning, accelerated partial breast irradiation - IMRT planning

Sites

5 sites in 1 country